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IntroductIon
Successful clinical application of hematopoietic stem cells 
(HSCs) is critically dependent on their ability to give long-
term multilineage hematopoietic reconstitution (Weissman 
and Shizuru, 2008). Multiple studies have revealed the para-
digmatic transcription factors driving HSC self-renewal and 
differentiation to sustain multilineage hematopoiesis (Gött-
gens, 2015). Emerging evidence indicates that strict control of 
HSC metabolism is also essential for their life-long functions 
(Suda et al., 2011; Manesia et al., 2015), but the key meta-
bolic regulators that ensure stem cell integrity remain elusive. 
Although highly proliferative fetal liver (FL) HSCs use oxy-
gen-dependent pathways for energy generation (Suda et al., 
2011; Manesia et al., 2015), adult HSCs are known to suppress 
the flux of glycolytic metabolites into the mitochondrial tri-
carboxylic acid (TCA) cycle and heavily rely on glycolysis to 
maintain their quiescent state (Simsek et al., 2010; Takubo et 
al., 2013; Wang et al., 2014). Whereas pharmacological inhibi-
tion of glycolytic flux into the TCA cycle enhances HSC ac-
tivity upon transplantation (Takubo et al., 2013), severe block 
of glycolysis (i.e., Ldha deletion) and a consequent elevated 
mitochondrial respiration abolishes HSC maintenance (Wang 
et al., 2014). The switch from glycolysis to mitochondrial ox-
idative metabolism is essential for adult HSC differentiation 
rather than maintenance of their self-renewing pool (Yu et 
al., 2013). Leukemia-initiating cells (LICs) are even more 
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dependent on glycolysis than normal HSCs (Wang et al., 
2014). Partial or severe block in glycolysis (elicited by de-
letion of Pkm2 or Ldha, respectively) and a metabolic shift 
to mitochondrial respiration efficiently suppress the develop-
ment and maintenance of LICs (Lagadinou et al., 2013; Wang 
et al., 2014). Thus, the maintenance of adult self-renewing 
HSCs and LICs appears to depend critically on glycolysis 
rather than the mitochondrial TCA, which is thought to be 
less important for this process. However, thus far, the require-
ment for any of the TCA enzymes in FL and adult HSC and 
LIC maintenance has not been investigated.
Genetic evidence in humans indicates that rare recessive 
mutations in the FH gene encoding a TCA enzyme fumarate 
hydratase (Fh1) result in severe developmental abnormalities, 
including hematopoietic defects (Bourgeron et al., 1994). 
Consistent with this, we also found that monozygous twins 
with recessive FH mutations (Tregoning et al., 2013) display 
leukopenia and neutropenia (Table S1), thus suggesting a role 
for FH in the regulation of hematopoiesis. Mitochondrial and 
cytosolic fumarate hydratase enzyme isoforms, both encoded 
by the same gene (called FH in humans and Fh1 in mice; 
Stein et al., 1994; Sass et al., 2001), catalyze hydration of fu-
marate to malate. Whereas mitochondrial Fh1 is an integral 
part of the TCA cycle, cytosolic Fh1 metabolizes fumarate 
generated during arginine synthesis, the urea cycle, and the 
purine nucleotide cycle in the cytoplasm (Yang et al., 2013). 
Autosomal dominant mutations in FH are associated with he-
reditary leiomyomatosis and renal cell cancer, indicating that 
FH functions as a tumor suppressor (Launonen et al., 2001; 
Tomlinson et al., 2002). Given that FH mutations have been 
associated with hematopoietic abnormalities and tumor for-
mation, here, we investigated the role of Fh1 in normal and 
malignant hematopoiesis.
reSultS
Fh1 is required for Fl hematopoiesis
Fh1 is uniformly expressed in mouse Lin–Sca-1+c-Kit+ (LSK) 
CD48−CD150+ HSCs, LSK CD48−CD150− multipotent 
progenitors, primitive hematopoietic progenitor cells (HPCs; 
i.e., LSK CD48+CD150− HPC-1 and LSK CD48+CD150+ 
HPC-2 populations), and Lin−Sca-1−c-Kit+ (LK) myeloid 
progenitors sorted both from the FL (the major site of defin-
itive hematopoiesis during development) of 14.5–days post-
coitum (dpc) embryos and adult BM (Fig. 1 A). To determine 
the requirement for Fh1 in HSC maintenance and multilin-
eage hematopoiesis, we conditionally deleted Fh1 specifically 
within the hematopoietic system shortly after the emergence 
of definitive HSCs using the Vav-iCre deleter strain (de Boer 
et al., 2003). We bred Fh1fl/fl mice (Pollard et al., 2007) with 
Vav-iCre mice and found no viable Fh1fl/fl;Vav-iCre offspring 
(Table S2). Fh1fl/fl;Vav-iCre embryos were recovered at 14.5 dpc 
at normal Mendelian ratios, suggesting fetal or perinatal le-
thality. FLs isolated from Fh1fl/fl;Vav-iCre embryos appeared 
abnormally small and pale indicating severe impairment in 
FL hematopoiesis (Fig. 1 B). Fh1 loss from the hematopoi-
etic system was confirmed by the absence of Fh1 transcripts 
(Fig.  1  C) in CD45+ and c-Kit+ hematopoietic cells from 
Fh1fl/fl;Vav-iCre FLs and absence of Fh1 protein in FL c-Kit+ 
cells from Fh1fl/fl;Vav-iCre embryos (Fig.  1  D). Whereas 
Fh1fl/fl;Vav-iCre FLs had decreased numbers of hematopoietic 
cells because of reduced numbers of differentiated lineage+ 
(Lin+) cells, the numbers of primitive FL Lin− cells remained 
unchanged (Fig. 1 E). Colony-forming cell (CFC) assays in-
dicated the failure of Fh1-deficient FL cells to differentiate 
(Fig.  1  F). Analyses of erythroid differentiation revealed a 
block of erythropoiesis resulting in severe anemia (Fig. 1 G). 
Fh1 is therefore essential for multilineage differentiation of 
FL stem and/or progenitor cells.
Fh1 is essential for HSc maintenance
Next, we asked whether Fh1 is required for the maintenance 
of the stem and progenitor cell compartments in FLs. FLs 
from Fh1fl/fl;Vav-iCre embryos had normal absolute num-
bers of LK myeloid progenitors (Fig.  1  H) and LSK stem 
and primitive progenitor cells (Fig. 1 I) but displayed an in-
crease in total numbers of HSCs compared with control FLs 
(Fig. 1 J). To test the repopulation capacity of Fh1-deficient 
HSCs, we transplanted 100 CD45.2+ HSCs sorted from 14.5-
dpc FLs into lethally irradiated syngeneic CD45.1+/CD45.2+ 
recipients and found that Fh1-deficient HSCs failed to re-
constitute short-term and long-term hematopoiesis (Fig. 1, 
K and L). To test the possibility that Fh1-deficient FLs contain 
stem cell activity outside the immunophenotypically defined 
LSK CD48−CD150+ HSC compartment, we transplanted un-
fractionated FL cells from Fh1fl/fl;Vav-iCre and control em-
bryos into lethally irradiated recipient mice (together with 
support BM cells) and found that Fh1-deficient FL cells failed 
to repopulate the recipients (Fig. 1 M). Thus, Fh1 is dispens-
able for HSC survival and expansion in the FL but is critically 
required for HSC maintenance upon transplantation.
To establish the requirement for Fh1 in adult HSC 
maintenance, we generated Fh1fl/fl;Mx1-Cre mice in which 
efficient recombination is induced by treatment with 
polyinosinic :polycytidylic acid (pIpC; Kühn et al., 1995). 
We mixed CD45.2+ BM cells from untreated Fh1fl/fl;Mx1-
Cre, Fh1+/fl;Mx1-Cre, or control mice with CD45.1+ BM 
cells, transplanted them into recipient mice, and allowed 
for efficient reconstitution (Fig.  1  N). pIpC administration 
to the recipients of Fh1fl/fl;Mx1-Cre BM cells resulted in a 
progressive decline of donor-derived CD45.2+ cell chimerism 
in PB (Fig.  1  N) and a complete failure of Fh1-deficient 
cells to contribute to primitive and mature hematopoietic 
compartments of the recipients (Fig. 1 O). Therefore, Fh1 is 
critical for the maintenance of both FL and adult HSCs.
Fh1 deficiency results in cellular fumarate accumulation 
and decreased maximal mitochondrial respiration
We next investigated the biochemical consequences of Fh1 
deletion in primitive hematopoietic cells. To investigate how 
Fh1 loss affects the oxidative phosphorylation capacity of 
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Figure 1. Hematopoiesis-specific Fh1 deletion results in severe hematopoietic defects and loss of HSc activity. (A) Relative levels of Fh1 mRNA 
(normalized to Actb) in HSCs, multipotent progenitors (MPP), HPC-1 and HPC-2 populations, and LSK and LK cells sorted from 14.5-dpc FLs and BM of 
C57BL/6 adult (8–10 wk old) mice. n = 3. (B) FLs from 14.5-dpc Fh1fl/fl;Vav-iCre embryos are smaller and paler compared with Fh1+/fl;Vav-iCre and control 
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primitive FL c-Kit+ hematopoietic cells, we measured oxy-
gen consumption rate (OCR) under basal conditions and in 
response to sequential treatment with oligomycin (ATPase 
inhibitor), carbonyl cyanide-4-(trifluoromethoxy)phenylhy-
drazone (FCCP; mitochondrial uncoupler), and a concomi-
tant treatment with rotenone and antimycin A (complex I and 
III inhibitors, respectively). The basal OCR was not affected 
in Fh1-deficient FL c-Kit+ cells, suggesting that the majority 
of mitochondrial NADH (nicotinamide adenine dinucleo-
tide reduced) required for oxygen consumption in these cells 
originates from TCA-independent sources. However, the 
maximal OCR (after treatment with FCCP), which reflects 
maximal mitochondrial respiration, was profoundly decreased 
in Fh1-deficient cells (Fig. 2 A; but not in Fh1+/fl;Vav-iCre 
cells; not depicted), indicating that Fh1 deficiency may result 
in a compromised capacity to meet increased energy demands 
associated with metabolic stress or long-term survival (Yadava 
and Nicholls, 2007; Ferrick et al., 2008; Choi et al., 2009; van 
der Windt et al., 2012; Keuper et al., 2014). We also found 
that primitive Fh1-deficient FL hematopoietic cells failed 
to maintain ATP synthesis upon galactose-mediated inhibi-
tion of glycolysis (Fig. 2 B, left), consistent with an increased 
reliance on glycolysis for ATP production. Furthermore, 
Fh1-deficient c-Kit+ cells had increased expression of glucose 
transporters (Glut1 and Glut3) and key glycolytic enzymes 
Hk2 and Pfkp and displayed increased extracellular acidifica-
tion rate (ECAR), indicative of enhanced glycolysis (Fig. 2, 
C–D). Thus, Fh1 deficiency results in an increase in glycolytic 
flux and impaired maximal mitochondrial respiration.
To determine the impact of Fh1 deletion on fumarate 
levels, we performed mass spectrometry analyses. Fh1-defi-
cient FL c-Kit+ cells accumulated high levels of endogenous 
cellular fumarate (Fig. 2 E), consistent with previous obser-
vations in nonhematopoietic tissues harboring Fh1 mutation 
(Adam et al., 2013). Under the conditions of elevated fumarate, 
argininosuccinate is generated from arginine and fumarate by 
the reversed activity of the urea cycle enzyme argininosucci-
nate lyase (Zheng et al., 2013). We found that argininosucci-
nate is produced at high levels in Fh1-deficient c-Kit+ cells 
(Fig. 2 F). Furthermore, when accumulated at high levels, fu-
marate modifies cysteine residues in many proteins, forming 
S-(2-succinyl)-cysteine (2SC; Alderson et al., 2006; Adam et 
al., 2011; Bardella et al., 2011; Ternette et al., 2013). Fh1-de-
ficient c-Kit+ cells exhibited high immunoreactivity for 2SC 
(Fig. 2 G). Thus, primitive hematopoietic cells lacking Fh1 
have compromised maximal mitochondrial respiration, dis-
play increased glycolysis, fail to maintain normal ATP pro-
duction upon inhibition of glycolysis, and accumulate high 
levels of fumarate resulting in excessive protein succination.
efficient fumarate metabolism is essential for HSc 
maintenance and multilineage hematopoiesis
Mechanistically, the phenotypes observed upon Fh1 deletion 
could result from the genetic block in the TCA cycle or the 
accumulation of cellular fumarate (Pollard et al., 2007; Adam 
et al., 2011). To differentiate between these two mechanisms, 
we used mice ubiquitously expressing a human cytoplasmic 
isoform of FH (FHCyt, which lacks the mitochondrial tar-
geting sequence and therefore is excluded from the mito-
chondria; Adam et al., 2013). FHCyt does not restore defects 
in mitochondrial oxidative metabolism but normalizes levels 
of total cellular fumarate (O’Flaherty et al., 2010; Adam et 
al., 2013). Although primitive hematopoietic cells from FLs 
of Fh1fl/fl;FHCyt;Vav-iCre embryos had normal mitochondrial 
membrane potential (not depicted), they displayed defective 
maximal respiration (Fig.  2 A) and impaired compensatory 
mitochondrial ATP production upon inhibition of glycolysis 
(Fig. 2 B, right), as well as an increase in ECAR (Fig. 2 D) 
similar to Fh1fl/fl;Vav-iCre FL cells. Furthermore, primitive 
Fh1fl/fl;FHCyt;Vav-iCre FL cells had significantly reduced levels 
of cellular fumarate (Fig. 2 E) and argininosuccinate (Fig. 2 F) 
and undetectable immunoreactivity to 2SC (Fig.  2  G), in-
dicating that the biochemical consequences of fumarate ac-
cumulation were largely abolished by the FHCyt transgene 
expression. Although FHCyt transgene decreased overall cel-
lular levels of fumarate, argininosuccinate, and succinated 
proteins, we cannot exclude the possibility that fumarate is 
elevated in mitochondria and contributes to the impairment 
of mitochondrial function in the absence of mitochondrial 
Fh1. Collectively, although cells from Fh1fl/fl;FHCyt;Vav-iCre 
FLs displayed impaired maximal respiration, they had cellular 
fumarate levels comparable with control cells.
embryos. (C) The absence of Fh1 transcripts in Fh1fl/fl;Vav-iCre FL CD45+ and c-Kit+ cells. Control, n = 3; Fh1fl/fl;Vav-iCre, n = 6. (D) Western blots for Fh1 and 
β-actin in FL c-Kit+ cells. (E) Total cellularity (the sum of Lin+ and Lin− cell numbers) in 14.5-dpc FLs of the indicated genotypes. Control, n = 17; Fh1+/fl;Vav-iCre, 
n = 11; Fh1fl/fl;Vav-iCre, n = 9. (F) CFC assay with FL cells. Control, n = 11; Fh1+/fl;Vav-iCre, n = 8; Fh1fl/fl;Vav-iCre, n = 4. (G) Erythropoiesis in 14.5-dpc FLs. 
Data are arranged from least to most differentiated: Ter119−CD71−, Ter119–CD71+, Ter119+CD71+, and Ter119+CD71–. Control, n = 11; Fh1+/fl;Vav-iCre, n = 8; 
Fh1fl/fl;Vav-iCre, n = 4. (H–J) Total number of LK cells (H), LSK cells (I), and HSCs (J) in 14.5-dpc FLs. Control, n = 17; Fh1+/fl;Vav-iCre, n = 11; Fh1fl/fl;Vav-iCre, 
n = 9. (K and L) Percentage of donor-derived CD45.2+ cells in PB (K) and total BM and the BM LSK cell compartment (L) of the recipient mice transplanted 
with 100 FL HSCs. n = 5–8 recipients per genotype. At least three donors were used per genotype. (M) Percentage of CD45.2+ cells in PB after transplantation 
of 200,000 total FL cells. n = 3–4 recipients per genotype. At least three donors were used per genotype. (N and O) Acute deletion of Fh1 from the adult 
hematopoietic system. 5 × 105 unfractionated CD45.2+ BM cells from untreated Fh1fl/fl (control), Fh1+/fl;Mx1-Cre, and Fh1fl/fl;Mx1-Cre C57BL/6 (8–10 wk old) 
mice were mixed with 5 × 105 CD45.1+ WT BM cells and transplanted into lethally irradiated CD45.1+/CD45.2+ recipients. 8 wk after transplantation, the 
recipients received six doses of pIpC. (N) Percentage of donor-derived CD45.2+ cells in PB. n = 5–10 recipients per genotype. n = 2 donors per genotype. 
(O) Percentage of CD45.2+ cells in the Lin+, Lin−, LK, and LSK cell compartments of the recipient mice 11 wk after pIpC treatment. n = 7–8 recipients per 
genotype. Data are mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (Mann-Whitney U test).
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Figure 2. cytosolic isoform of Fh1 restores normal steady-state hematopoiesis in Fh1fl/fl;Vav-icre mice. (A) OCR in FL c-Kit+ cells under basal 
conditions and after the sequential addition of oligomycin, FCCP, and rotenone and antimycin A. Control, n = 5; Fh1fl/fl;Vav-iCre, n = 3; control;FHCyt, 
n = 10; Fh1fl/fl;FHCyt;Vav-iCre, n = 5. (B) Oxidative phosphorylation–dependent ATP production in galactose (Gal)-treated FL c-Kit+ Fh1fl/fl;Vav-iCre and 
Fh1fl/fl;FHCyt;Vav-iCre cells. FL c-Kit+ cells were cultured in DMEM supplemented with either 25 mM glucose (Glu) or 25 mM Gal. The graph shows the ratio of 
ATP produced in the presence of Gal (permissive for oxidative phosphorylation only) to ATP generated in the presence of Glu (permissive for both oxidative 
phosphorylation and glycolysis). Control, n = 9; Fh1fl/fl;Vav-iCre, n = 9; control;FHCyt, n = 6; Fh1fl/fl;FHCyt;Vav-iCre, n = 10. (C) Relative expression (normalized 
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Notably, Fh1fl/fl;FHCyt;Vav-iCre mice were born at 
normal Mendelian ratios (Table S3) and matured to adult-
hood without any obvious defects. BM cells from adult 
Fh1fl/fl;FHCyt;Vav-iCre mice efficiently generated myeloid col-
onies (Fig. 2 H), had normal BM cellularity (Fig. 2 I), and 
displayed multilineage hematopoiesis (Fig.  2, J and K), de-
spite reduced numbers of B cells (Fig.  2  K). Furthermore, 
they had unaffected numbers of LK myeloid progenitor cells 
(Fig. 2 L) and increased numbers of LSK cells (Fig. 2 M) and 
HSCs (Fig. 2 N). Therefore, it is critical that HSCs and/or 
primitive progenitor cells efficiently metabolize fumarate to 
sustain hematopoietic differentiation. Finally, HSCs that ac-
quire mitochondrial Fh1 deficiency (which abolishes maxi-
mal mitochondrial respiration) shortly after their emergence 
manage to survive, expand in the FL, colonize the BM, and 
sustain steady-state multilineage hematopoiesis, implying that 
mitochondrial Fh1 is largely dispensable for these processes.
Mitochondrial Fh1 deficiency compromises HSc self-renewal
To stringently test the long-term self-renewal capacity of 
HSCs lacking mitochondrial Fh1, we performed serial trans-
plantation assays. We transplanted 100 HSCs from FLs of 
Fh1fl/fl;FHCyt;Vav-iCre, Fh1fl/fl;Vav-iCre, and control 14.5-dpc 
embryos together with 200,000 support BM cells. Whereas 
Fh1fl/fl;Vav-iCre HSCs failed to repopulate the recipients, 
Fh1fl/fl;FHCyt;Vav-iCre HSCs contributed to primitive and 
more mature hematopoietic compartments of the recipient 
mice (Fig. 3 A). Primary recipients of Fh1fl/fl;FHCyt;Vav-iCre 
HSCs displayed efficient myeloid lineage reconstitution, 
whereas B and T lymphoid–lineage reconstitution was less ro-
bust (Fig. 3 B), suggesting that mitochondrial Fh1 is required 
for lymphoid cell differentiation or survival. Next, we sorted 
BM LSK cells from the primary recipients and retransplanted 
them into secondary recipients. Fh1fl/fl;FHCyt;Vav-iCre HSCs 
failed to contribute to the BM hematopoietic compartments 
of the recipients 20 wk after transplantation (Fig. 3 C). There-
fore, HSCs lacking mitochondrial Fh1 display progressive loss 
of self-renewal potential upon serial transplantation.
Hematopoietic defects upon Fh1 deletion  
are not caused by oxidative stress or the activation  
of nrf2-dependent pathways
Because elevated cellular fumarate is a major cause of hema-
topoietic defects in Fh1fl/fl;Vav-iCre FLs, we next explored 
potential mechanisms through which fumarate impairs FL 
hematopoiesis. In nonhematopoietic tissues, fumarate suc-
cinates cysteine residues of biologically active molecules 
(including glutathione [GSH]; Sullivan et al., 2013; Zheng 
et al., 2015) and numerous proteins (Adam et al., 2011; Ter-
nette et al., 2013). Elevated fumarate causes oxidative stress 
by succinating GSH and, thus, generating succinic GSH 
and depleting the GSH pool (Sullivan et al., 2013; Zheng 
et al., 2015). We found that reactive oxygen species (ROS) 
were modestly increased in Fh1fl/fl;Vav-iCre FL c-Kit+ cells 
compared with control cells (Fig. 4 A). The quantity of suc-
cinic GSH was elevated in Fh1fl/fl;Vav-iCre FL c-Kit+ cells 
(Fig. 4 B), but succinic GSH constituted only ∼1.5% of the 
total pool of GSH species (Fig. 4 C). Furthermore, we found 
that administration of the antioxidant N-acetylcysteine 
(NAC) to timed-mated pregnant females did not rescue the 
reduced FL cellularity (not depicted) and failed to reverse 
decreased numbers of Lin+ FL cells (Fig. 4 D). Finally, HSCs 
sorted from NAC-treated Fh1fl/fl;Vav-iCre FLs failed to re-
constitute hematopoiesis in NAC-treated recipient mice 
(Fig.  4  E). Therefore, oxidative stress caused by GSH de-
pletion does not cause hematopoietic defects resulting from 
fumarate accumulation.
Loss of Fh1 in renal cysts is associated with up- 
regulation of the Nrf 2-mediated antioxidant response 
pathway because of fumarate-mediated succination of 
Keap1, which normally promotes Nrf 2 degradation (Adam 
et al., 2011). However, the analyses of global gene expres-
sion profiling of FL Lin−c-Kit+ primitive hematopoietic 
cells from 14.5-dpc Fh1fl/fl;Vav-iCre and control embryos 
revealed no significant enrichment for Nrf 2 signature 
(Fig.  4  F). Thus, the activation of the Nrf 2-dependent 
pathways is not responsible for defective hematopoiesis 
in Fh1fl/fl;Vav-iCre FLs.
Fh1 deficiency in primitive hematopoietic cells has no 
impact on the Hif-1–dependent pathways and does not 
affect global 5-hydroxymethylcytosine levels
Fumarate is known to competitively inhibit 2-oxoglutarate 
(2OG)–dependent oxygenases including Hif prolyl hy-
droxylase Phd2 resulting in stabilization of Hif-1α (Adam 
et al., 2011). Given that Phd2 deletion and stabilization of 
Hif-1α results in HSC defects (Takubo et al., 2010; Singh 
et al., 2013), we asked whether elevated fumarate increases 
to Actb) of genes involved in glycolysis in FL c-Kit+ cells. n = 4–5 per genotype. (D) ECAR under basal conditions in 14.5-dpc FL c-Kit+ cells. Control, n = 6; 
Fh1fl/fl;Vav-iCre, n = 5; control;FHCyt, n = 10; Fh1fl/fl;FHCyt;Vav-iCre, n = 4. (E and F) Fumarate (E) and argininosuccinate (F) levels in FL c-Kit+ cells measured 
using LC-MS. Control, n = 6; Fh1fl/fl;Vav-iCre, n = 4; control;FHCyt, n = 6; Fh1fl/fl;FHCyt;Vav-iCre, n = 13. (G) 14.5-dpc FL cell extracts were immunoblotted 
with a polyclonal anti-2SC antibody. α-Tubulin was used as a loading control. Data are representative of two independent experiments. (H) CFU assays 
performed with BM cells from 8–10-wk-old mice of the indicated genotypes. CFU-red, CFU-erythroid and/or megakaryocyte; CFU-G, CFU-granulocyte; 
CFU-M, CFU-monocyte/macrophage; CFU-GM, CFU–granulocyte and monocyte/macrophage; CFU-Mix, at least three of the following: granulocyte, eryth-
roid, monocyte/macrophage, and megakaryocyte. n = 3–5 per genotype and are representative of three independent experiments. (I) Total number of BM 
nucleated cells obtained from two tibias and two femurs of 8–10-wk-old mice. n = 3–4 per genotype. (J–N) Total numbers of CD11b+Gr-1+ myeloid cells (J), 
CD19+B220+ B cells (K), LK cells (L), LSK cells (M), and HSCs (N) in two tibias and two femurs. n = 3–4 per genotype. Data are mean ± SEM. *, P < 0.05; **, P 
< 0.01; ***, P < 0.001; ****, P < 0.0001 (Mann-Whitney U test).
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the Hif-1α protein levels upon Fh1 deletion in primitive 
hematopoietic cells. We found that Hif-1α protein was 
undetectable in Fh1fl/fl;Vav-iCre and control FL c-Kit+ 
cells (Fig. 4 G), and additional deletion of Hif-1α in Fh1- 
deficient embryos failed to rescue embryonic lethality (not 
depicted), restore total FL cellularity, reverse decreased 
FL Lin+ cell numbers, or normalize elevated numbers of 
FL HSCs (Fig. 4 H). Thus, Hif-1α is not involved in gen-
erating hematopoietic defects in Fh1fl/fl;Vav-iCre FLs. 
Given that fumarate can inhibit the Tet family of 5-meth-
ylcytosine hydroxylases (Xiao et al., 2012), we measured 
the levels of 5-hydroxymethylcytosine in Fh1fl/fl;Vav-iCre 
and control c-Kit+ cells and did not find any differences 
(not depicted), suggesting that fumarate-mediated Tet in-
hibition does not play a major role in generating hemato-
poietic defects in Fh1fl/fl;Vav-iCre FLs.
Fh1 deletion results in increased histone H3 trimethylation 
in primitive hematopoietic cells
Emerging evidence indicates that 2OG-dependent JmjC do-
main–containing histone demethylases (KDMs) play import-
ant roles in HSC biology and hematopoiesis (Stewart et al., 
2015; Andricovich et al., 2016). Given that fumarate inhibits 
enzymatic activity of KDMs (Xiao et al., 2012), we examined 
the abundance of H3K4me3, H3K9me3, H3K27me3, and 
H3K36me3 in nuclear extracts from FL c-Kit+ cells isolated 
from 14.5-dpc Fh1fl/fl;Vav-iCre and control embryos. West-
ern blot analyses revealed an increase in levels of H3K9me3, 
H3K27me3, and H3K36me3 but not H3K4me3 in Fh1- 
deficient cells (Fig. 4, I and J). Although these data suggest 
that Fh1 deficiency results in enhanced trimethylation of 
H3, the identity of KDMs that are inhibited by fumarate 
and the causal roles for increased H3 trimethylation in me-
Figure 3. Mitochondrial Fh1 is essential 
for HSc self-renewal. (A–C) 100 FL HSCs 
were transplanted into lethally irradiated 
8–10-wk-old C57BL/6 CD45.1+/CD45.2+ re-
cipient mice together with 2 × 105 CD45.1+ 
syngeneic competitor BM cells. The primary 
recipients were analyzed 20 wk after trans-
plantation. 2,000 CD45.2+LSK cells were sorted 
from their BM and transplanted into second-
ary recipients together with competitor BM 
cells. Secondary recipients were analyzed 20 
wk after transplantation. (A) Percentage of 
CD45.2+ cells in the Lin+, Lin−, LK, LSK, and HSC 
compartments in the BM of primary recipients. 
n = 4–5 recipients per donor. (B) Percentage 
of CD45.2+ cells in the monocyte, neutrophil, 
B cell, and T cell compartments in the PB of pri-
mary recipients. n = 4–5 recipients per donor. 
Number of donors used in A and B: control, 
n = 6; Fh1+/fl;Vav-iCre, n = 2; Fh1fl/fl;Vav-iCre, n = 
2; control;FHCyt, n = 6; Fh1+/fl;FHCyt;Vav-iCre, n 
= 3; Fh1fl/fl;FHCyt;Vav-iCre, n = 3. (C) Percentage 
of CD45.2+ cells in the Lin+, Lin−, LK, LSK, and 
HSC compartments in the BM of the secondary 
recipients. n = 4–5 recipients per donor. Num-
ber of donors: control, n = 3; control;FHCyt, 
n = 4; Fh1+/fl;FHCyt;Vav-iCre, n = 2; Fh1fl/fl;FH-
Cyt;Vav-iCre, n = 3. Data are mean ± SEM. *, P < 
0.05; **, P < 0.01 (Mann-Whitney U test). o
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Figure 4. Molecular consequences of Fh1 deletion in primitive hematopoietic cells. (A) Intracellular ROS in FL c-Kit+ cells. The mean of mean 
fluorescence intensities ± SEM is shown. Control, n = 6; Fh1fl/fl;Vav-iCre, n = 3. (B and C) GSH species in 14.5-dpc FL c-Kit+ cells measured using LC-MS. 
Succinic GSH levels (arbitrary units; B) and percentage of Succinic GSH within the total GSH species (C) are shown. Control, n = 6; Fh1fl/fl;Vav-iCre, n = 3. 
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diating HSC and hematopoietic defects upon Fh1 deletion 
remain to be elucidated.
Fh1 deletion promotes a gene expression signature  
that facilitates hematopoietic defects
To understand the molecular signatures associated with Fh1 
deficiency, we performed gene expression profiling of FL 
Lin−c-Kit+ primitive hematopoietic cells from Fh1fl/fl;Vav-iCre 
and control embryos. We found that genes up-regulated in 
Fh1-deficient cells are highly enriched in categories related to 
apoptosis in response to ER stress, protein metabolic process/
protein translation, and unfolded protein response (Fig. 4, K 
and L). Down-regulated genes are enriched in pathways re-
lated to heme biosynthesis, erythroid and myeloid function, 
and the cell cycle (Fig. 4 K). Although further detailed work 
will be needed to experimentally verify this, we propose that 
enhanced ER stress, unfolded protein response, and increased 
protein translation (which are known to contribute to HSC 
depletion and hematopoietic failure; Miharada et al., 2014; 
Signer et al., 2014; van Galen et al., 2014) may be responsible 
for hematopoietic defects upon Fh1 deletion.
Fh1 deficiency abolishes leukemic 
transformation and lIc functions
Although FH is a tumor suppressor (i.e., FH mutations 
result in hereditary leiomyomatosis and renal-cell cancer) 
and fumarate is proposed to function as an oncometabolite 
(Yang et al., 2013), the role of FH in leukemic transforma-
tion remains unknown. Given that human acute myeloid 
leukemia (AML) cells express high levels of FH protein 
(López-Pedrera et al., 2006; Elo et al., 2014) and enzymatic 
activity of FH is increased in AML samples compared with 
cells from normal controls (Tanaka and Valentine, 1961), we 
next investigated the role for Fh1 in leukemic transforma-
tion. We used a mouse model of AML in which the devel-
opment and maintenance of LICs is driven by Meis1 and 
Hoxa9 oncogenes (Wang et al., 2010; Vukovic et al., 2015). 
Meis1 and Hoxa9 are frequently overexpressed in several 
human AML subtypes (Lawrence et al., 1999; Drabkin et 
al., 2002), and their overexpression in mouse hematopoi-
etic stem and progenitor cells generates self-renewing LICs 
(Kroon et al., 1998). In the Meis1/Hoxa9 model used here, 
the FL LSK or c-Kit+ cell populations are transduced with 
retroviruses expressing Meis1 and Hoxa9 and are serially 
replated, generating a preleukemic cell population, which, 
upon transplantation to primary recipients, develops into 
LICs causing AML. LICs are defined by their capacity to 
propagate AML with short latency in secondary recipients 
(Somervaille and Cleary, 2006; Yeung et al., 2010; Vukovic 
et al., 2015). We found that Fh1fl/fl;Vav-iCre FL stem and 
progenitor cells transduced with Meis1/Hoxa9 (Fig.  5 A) 
failed to generate colonies in methylcellulose (Fig. 5 B). To 
corroborate these findings, we used retroviruses expressing 
MLL fusions which are frequently found in acute mono-
blastic leukemia (AML M5) and are associated with an 
unfavorable prognosis in AML, namely MLL-ENL (fusion 
oncogene resulting from t[11;19]) and MLL-AF9 (result-
ing from t[9;11]; Krivtsov and Armstrong, 2007; Lavallée et 
al., 2015). We also used AML1-ETO9a, a splice variant of 
AML1-ETO that is frequently expressed in t(8;21) patients 
with AML M2, and its high expression correlates with poor 
AML prognosis (Jiao et al., 2009). MLL fusions and AML1-
ETO9a drive leukemogenesis through distinct pathways and 
are frequently used to transform mouse hematopoietic cells 
(Zuber et al., 2009; Smith et al., 2011; Velasco-Hernandez et 
al., 2014). We found that Fh1-deficient cells transduced with 
MLL-ENL, MLL-AF9, and AML1-ETO9a were unable to 
generate colonies (Fig. 5 B), indicating the requirement for 
Fh1 in in vitro transformation. Next, we determined the 
impact of Fh1 deletion on the colony formation capacity 
of preleukemic cells (Fig. 5 C). We transduced Fh1+/+ and 
Fh1fl/fl FL LSK cells with Meis1 and Hoxa9 retroviruses, and 
after three rounds of replating, we infected the transformed 
cells with Cre lentiviruses. Fh1fl/fl cells expressing Cre failed 
to generate colonies in CFC assays (Fig.  5 D). Thus, Fh1 
deletion inhibits the generation of preleukemic cells and 
abolishes their clonogenic capacity.
To determine the requirement for Fh1 in LICs, LSK 
cells from Fh1+/+ and Fh1fl/fl FLs were transduced with 
Meis1 and Hoxa9 retroviruses and transplanted into pri-
(D and E) Pregnant females were treated with NAC administered 7 d before the embryo harvest. (D) Lin+ cell numbers in 14.5-dpc FLs. Control, n = 15; 
Fh1fl/fl;Vav-iCre, n = 6; control + NAC, n = 4; Fh1fl/fl;Vav-iCre + NAC, n = 4. (E) 600,000 total FL cells of 14.5-dpc embryos from NAC-treated pregnant females 
were transplanted into lethally irradiated CD45.1+/CD45.2+ recipient mice together with 200,000 CD45.1+ competitor BM cells. Recipients were continuously 
treated with NAC. Data represent percentage of donor-derived CD45.2+ cells in PB 3 wk after transplantation. n = 10–11 recipients per genotype. n = 4 
donors per genotype. (F) GSEA showing that the Nrf2 signature is not significantly affected in Fh1-deficient (Fh1 KO) FL Lin−c-Kit+ cells. FDR, false discovery 
rate; NES, normalized enrichment score. (G) Western blots for Hif-1α and β-actin in c-Kit+ cells from 14.5-dpc FLs. n = 3 per genotype. CoCl2-treated FL 
c-Kit+ cells were used as a positive control for Hif-1α. Asterisks indicate nonspecific bands. (H) Total FL cellularity and total number of Lin+ cells and HSCs in 
14.5-dpc FLs. Fh1fl/fl;Hif-1α+/+, n = 12; Fh1fl/fl;Hif-1α+/+;Vav-iCre, n = 9; Fh1fl/fl;Hif-1αfl/fl, n = 6; Fh1+/fl;Hif-1αfl/fl;Vav-iCre, n = 5; Fh1fl/fl;Hif-1αfl/fl;Vav-iCre, n = 
4. (I) Western blot for H3K4me3, H3K9me3, H3K27me3, H3K36me3, and total H3 in 14.5-dpc FL c-Kit+ cells. n = 3 per genotype. (J) Quantification of the data 
(normalized to total H3) shown in panel I. n = 3 per genotype. (K) Biological processes (presented as –log10 [p-value]) that are enriched in up-regulated and 
down-regulated genes in Fh1-deficient FL Lin−c-Kit+ cells versus control cells. Analysis was performed using the Gene Ontology Consortium database. The 
dashed gray line indicates P = 0.05. (L) Signature enrichment plots from GSEA analyses using unfolded protein response, apoptosis in response to ER stress, 
and protein translation signature gene sets. (F, K, and L) Gene expression analysis was performed using Lin−c-Kit+ cells from three Fh1fl/fl (WT) and four 
Fh1fl/fl;Vav-iCre (Fh1 KO) embryos. Data are mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (Mann-Whitney U test).
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mary recipients (Fig. 5 C). LICs isolated from leukemic pri-
mary recipient mice were infected with Cre lentivirus and 
plated into methylcellulose. We found that Fh1-deficient 
LICs were unable to generate colonies (Fig. 5 E). Next, we 
investigated the requirement for FH in human established 
leukemic cells by knocking down the expression of FH in 
human AML (M5) THP-1 cells harboring MLL-AF9 trans-
location. We generated lentiviruses expressing three inde-
pendent short hairpins (i.e., FH shRNA 1–3) targeting FH 
and a scrambled shRNA sequence. Based on knockdown 
efficiency (Fig. 5, F and G), we selected FH shRNA1 and 
FH shRNA3 for further experiments. FH knockdown in-
creased apoptosis of THP-1 cells (Fig. 5 H) and decreased 
their ability to form colonies (Fig. 5  I). Therefore, Fh1 is 
required for survival of both mouse LICs and human estab-
lished leukemic cells. Finally, we conclude that the tumor 
suppressor functions of FH are tissue specific and do not 
extend to hematopoietic cells.
Mitochondrial Fh1 is necessary for AMl development  
but is not required for disease maintenance
Next, we investigated the impact of mitochondrial 
Fh1 deficiency on in vitro transformation and devel-
opment and maintenance of LICs (Fig.  6, A–C). FL 
Fh1fl/fl;FHCyt;Vav-iCre cells transduced with Meis1/
Hoxa9 retroviruses had normal serial replating capacity 
(Fig. 6 B), and the established preleukemic cells had nor-
mal proliferative capacity and cell-cycle status (not de-
picted). Thus, elevated fumarate is largely responsible for 
the inability of Fh1fl/fl;Vav-iCre stem and progenitor cells 
to undergo in vitro transformation. To establish the re-
quirement for mitochondrial Fh1 in AML development in 
vivo, we transplanted control (Fh1fl/fl), control;FHCyt, and 
Fh1fl/fl;FHCyt;Vav-iCre Meis1/Hoxa9-transduced pre-
leukemic cells into sublethally irradiated recipient mice 
(Fig. 6 A). We found that the percentage of recipients of 
Fh1fl/fl;FHCyt;Vav-iCre cells that developed terminal AML 
Figure 5. Fh1 is required for leukemic transformation. (A) 14.5-dpc FL c-Kit+ cells were transduced with Meis1/Hoxa9, MLL-AF9, MLL-ENL, and AML1-
ETO9a retroviruses and plated into methylcellulose. (B) Colony counts 6 d after plating are shown. n = 4–5 per genotype. (C) Fh1+/+ and Fh1fl/fl (without 
Vav-iCre) FL LSK cells were co-transduced with Meis1 and Hoxa9 retroviruses and serially replated. The cells were subsequently infected with a bicistronic 
lentivirus expressing iCre and a Venus reporter. Venus+ cells were plated into methylcellulose. In parallel, Fh1+/+ and Fh1fl/fl preleukemic cells were trans-
planted into recipient mice. LICs (CD45.2+c-Kit+ cells) were sorted from the BM of leukemic recipients, transduced with Cre lentivirus, and plated into meth-
ylcellulose. (D) Number of colonies generated by Cre-expressing preleukemic cells. n = 3 per genotype. (E) Number of colonies generated by Cre-expressing 
LICs. n = 3 per genotype. (F) Relative levels of FH mRNA (normalized to ACTB) in untransduced THP-1 cells and THP-1 cells transduced with lentiviruses 
expressing scrambled shRNA (Scr shRNA) and three different shRNAs targeting FH (FH shRNA1, FH shRNA2, and FH shRNA3). n = 3. (G) Western blot for FH 
and β-actin in THP-1 cells described in Fig. 5 F. (H) Apoptosis assays performed with THP-1 cells transduced with lentiviruses expressing scrambled shRNA, 
FH shRNA1, and FH shRNA3. The graph depicts the percentage of annexin V+DAPI− cells in early apoptosis and annexin V+DAPI+ in late apoptosis. n = 4. 
(I) CFC assays with THP-1 cells expressing scrambled shRNA, FH shRNA1, and FH shRNA3. n = 5. Data are mean ± SEM. *, P < 0.05 (Mann-Whitney U test).
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was significantly reduced (and the disease latency was 
extended) compared with recipients of control and con-
trol;FHCyt cells (Fig. 6 C). Finally, OCR measurements in 
LICs sorted from those recipients of Fh1fl/fl;FHCyt;Vav-iCre 
cells that succumbed to AML revealed that 
Fh1fl/fl;FHCyt;Vav-iCre LICs had defective maximal mi-
tochondrial respiration compared with control and con-
trol;FHCyt LICs (not depicted). Thus, mitochondrial Fh1 is 
required for efficient generation of LICs and AML develop-
ment in a Meis1/Hoxa9-driven model of leukemogenesis.
Given that mitochondrial Fh1 was important for leu-
kemia initiation, we next asked whether inducible deletion 
of mitochondrial Fh1 from leukemic cells impacts on leu-
kemia propagation and LIC maintenance (Fig.  6, D–J). We 
transduced control and Fh1fl/fl;FHCyt;Mx1-Cre FL LSK cells 
with Meis1/Hoxa9 retroviruses, and after serial replating, the 
resultant preleukemic cells were transplanted into primary 
recipient mice (Fig. 6 D). Upon disease diagnosis (i.e., 20% 
of CD45.2+ leukemic cells in the PB), the mice received 
eight pIpC doses (Fig.  6 D). Recipients of both control and 
Figure 6. Mitochondrial Fh1 is necessary for efficient leukemia establishment but is not required for AMl propagation. (A) Control, Fh1fl/fl;FHCyt 
(i.e., Control;FHCyt), and Fh1fl/fl;FHCyt;Vav-iCre FL LSK cells were co-transduced with Meis1 and Hoxa9 retroviruses and serially replated. 100,000 c-Kit+ pre-
leukemic cells were transplanted into sublethally irradiated recipient mice. (B) CFC counts at each replating. Data are mean ± SEM. n = 6–8 per genotype. 
(C) Kaplan-Meier survival curve of primary recipient mice. n = 8–10 recipients per genotype and 4 donors per genotype. ***, P < 0.001 (log-rank [Mantel-Cox] 
test). (D) Control and Fh1fl/fl;FHCyt;Mx1-Cre FL LSK cells were co-transduced with Meis1 and Hoxa9 retroviruses and serially replated. The resultant preleu-
kemic cells were transplanted into sublethally irradiated recipients. Once leukemic CD45.2+ cells reached 20% in the PB of recipient mice, the recipients 
received eight doses of pIpC. 10,000 LICs (CD45.2+c-Kit+) from primary recipients were transplanted into secondary recipients. (E) Kaplan-Meier survival 
curve of primary recipient mice. pIpC treatment was initiated 5 wk after transplantation. n = 5–7 recipients per genotype. (F) Percentage of CD45.2+ cells 
in BM of primary recipient mice with terminal leukemia. Data are mean ± SEM. n = 5–7 recipients per genotype. (G) Genomic PCR assessing Fh1 deletion 
before pIpC (top) and after pIpC (bottom) treatment. Δ, excised allele; fl, undeleted conditional allele. (H) OCR in LICs isolated from the BM of primary 
recipients treated with pIpC. OCR was assayed as described in Fig 2 A. Data are mean ± SEM. n = 3–5. *, P < 0.05 (Mann-Whitney U test). (I) Kaplan-Meier 
survival curve of secondary recipients transplanted with LICs sorted from leukemic primary recipients. n = 10 per genotype. (J) Representative gel showing 
PCR amplification of genomic DNA from the total BM of secondary recipients with terminal leukemia.
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Fh1fl/fl;FHCyt;Mx1-Cre cells equally succumbed to terminal 
AML (Fig. 6, E and F). After confirming efficient Fh1 dele-
tion (Fig. 6 G) and defective maximal respiration (Fig. 6 H), 
we isolated LICs from the BM of leukemic primary recip-
ient mice and transplanted them into secondary recipients. 
We found that LICs lacking mitochondrial Fh1 and control 
LICs equally efficiently caused leukemia in secondary recipi-
ents (Fig. 6, I and J). Thus, mitochondrial Fh1 is necessary for 
efficient LIC generation but is not required for their ability to 
efficiently propagate Meis1/Hoxa9-driven leukemia.
dIScuSSIon
By performing genetic dissection of multifaceted functions 
of the key metabolic gene Fh1, we have uncovered a previ-
ously unknown requirement for fumarate metabolism in the 
hematopoietic system. We conclude that efficient utilization 
of intracellular fumarate is required to prevent its potentially 
toxic effects and is central to the integrity of HSCs and he-
matopoietic differentiation. Furthermore, although fumarate 
promotes oncogenesis in the kidney (Yang et al., 2013), it has 
the opposite effect in the hematopoietic system, i.e., it inhibits 
leukemic transformation. Our data, indicating a detrimental 
impact of fumarate on hematopoiesis, collectively with fuma-
rate’s functions as an oncometabolite in nonhematopoietic 
tumors (Yang et al., 2013), or a protective role within the 
myocardium (Ashrafian et al., 2012), highlight distinct func-
tions of fumarate in different tissues.
Elevated fumarate within the hematopoietic system is 
likely to perturb multiple biochemical mechanisms. Fumarate 
is known to inhibit 2OG-dependent oxygenases, including 
HIF-hydroxylase Phd2 (Hewitson et al., 2007), the Tet en-
zymes, and KDMs (Xiao et al., 2012), and as a consequence, 
tumor cells with FH mutations have increased HIF-1α sta-
bility and display a hypermethylator phenotype (Isaacs et al., 
2005; Pollard et al., 2007; Letouzé et al., 2013; Castro-Vega 
et al., 2014). We found that hematopoietic defects resulting 
from elevated fumarate are most likely generated through 
the Hif-1–independent and Tet-independent mechanisms. 
However, consistent with the ability of fumarate to inhibit 
KDMs, we found that levels of H3K9me3, H3K27me3, and 
H3K36me3 were elevated in primitive hematopoietic cells 
lacking Fh1. Although detailed underlying mechanisms re-
main to be elucidated, we propose that elevated fumarate may 
cause the observed phenotypes by inhibiting these KDMs 
that are essential for normal hematopoiesis and HSC func-
tions, including KDM5B (Stewart et al., 2015) and KDM2B 
(Andricovich et al., 2016).
Fumarate is also known to cause succination of cysteine 
residues of numerous proteins (e.g., Keap1, which normally 
promotes Nrf2 degradation; Adam et al., 2011; Ternette et 
al., 2013) or GSH (Sullivan et al., 2013; Zheng et al., 2015). 
However, our data indicated that hematopoietic defects upon 
Fh1 deletion are unlikely to be mediated by Nrf 2 activation 
or GSH depletion. Given our findings that Fh1-deficient cells 
have increased signatures of ER stress and unfolded protein 
response, it will be of high interest to determine whether 
increased global protein succination in Fh1-deficient cells re-
sults in protein misfolding in HSCs, leading to the activation 
of unfolded protein response, which is detrimental to HSC 
integrity (van Galen et al., 2014).
Fh1 deletion with the simultaneous reexpression of 
cytosolic FH allowed us to investigate the genetic require-
ment for mitochondrial Fh1 in long-term HSC functions. 
Our serial transplantation assays revealed that mitochondrial 
Fh1 was essential for HSC self-renewal, indicating a key role 
for an intact TCA cycle in HSC maintenance. Intriguingly, 
although mitochondrial Fh1 deficiency did not affect my-
eloid output under steady-state conditions and upon trans-
plantation, the lack of mitochondrial Fh1 had an impact on 
the lymphoid output. These data imply differential require-
ments for the intact TCA cycle in lineage commitment and/
or differentiation of primitive hematopoietic cells, meriting 
further investigations.
Both self-renewing HSCs and LICs are thought to 
rely heavily on glycolysis while they suppress the TCA cycle 
(Simsek et al., 2010; Wang et al., 2014). We used the genetic 
mitochondrial Fh1 deficiency to examine the differential re-
quirement for mitochondrial Fh1 in long-term HSC self-re-
newal and the development and maintenance of LICs. We 
conclude that self-renewing HSCs critically require intact 
mitochondrial Fh1 and the capacity for maximal mitochon-
drial respiration to maintain their pool. However, although 
mitochondrial Fh1 was necessary for LIC development, it had 
no impact on maintenance of LICs. Thus, we reveal a differ-
ential requirement for the mitochondrial TCA enzyme Fh1 
in normal hematopoiesis and Meis1/Hoxa9-driven leukemia 
propagation. The discovery of mechanisms underlying differ-
ent metabolic requirements in HSCs and LICs represents a 
key area for future investigations.
MAterIAlS And MetHodS
Mice
All mice were on a C57BL/6 genetic background. Fh1fl/fl 
(Pollard et al., 2007), Hif-1αfl/fl (Ryan et al., 2000; Vukovic 
et al., 2016), and V5-FHCyt (referred to as FHCyt; Adam et 
al., 2013) were described previously. Vav-iCre and Mx1-Cre 
were purchased from The Jackson Laboratory. All transgenic 
and knockout mice were CD45.2+. Congenic recipient mice 
were CD45.1+/CD45.2+. All experiments on animals were 
performed under UK Home Office authorization.
Flow cytometry
All BM and FL samples were stained and analyzed as described 
previously (Kranc et al., 2009; Mortensen et al., 2011; Guitart 
et al., 2013; Vukovic et al., 2016). BM cells were obtained by 
crushing tibias and femurs with a pestle and mortar. FL cells 
were obtained by mashing the tissue through a 70-µm strainer. 
Single-cell suspensions from BM, FL, or PB were incubated 
with Fc block and then stained with antibodies. For HSC 
analyses, after incubation with Fc block, unfractionated FL or 
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BM cell suspensions were stained with lineage markers con-
taining biotin-conjugated anti-CD4, anti-CD5, anti-CD8a, 
anti-CD11b (not used in FL analyses), anti-B220, anti–Gr-1, 
and anti-Ter119 antibodies together with APC-conjugated 
anti–c-Kit, APC/Cy7-conjugated anti–Sca-1, PE-conjugated 
anti-CD48, and PE-Cy7–conjugated anti-CD150 antibodies. 
Then, biotin-conjugated antibodies were stained with Pa-
cific blue–conjugated or PerCP-conjugated streptavidin. To 
distinguish CD45.2+ donor–derived HSCs in recipient mice, 
FITC-conjugated anti-CD45.1 and Pacific blue–conjugated 
anti-CD45.2 antibodies were included in the antibody cock-
tail. The multilineage reconstitution of recipient mice was 
determined by staining the BM or PB cell suspensions of the 
recipient mice with FITC-conjugated anti-CD45.1, Pacific 
blue–conjugated anti-CD45.2, PE-conjugated anti-CD4 and 
-CD8a, PE/Cy7-conjugated anti–Gr-1, APC-conjugated 
anti-CD11b, APC-Cy7–conjugated anti-CD19, and 
anti-B220. In all analyses, 7-AAD or DAPI was used for dead 
cell exclusion. Flow cytometry analyses were performed 
using an LSRFortessa flow cytometer (BD). Cell sorting was 
performed on a FAC SAria Fusion cell sorter (BD).
cFc assays
CFC assays were performed using MethoCult (M3434; 
STE MCE LL Technologies). Two replicates were used per 
group in each experiment. Colonies were tallied at day 10.
leukemic transformation
LSK cells were sorted from FLs of 14.5-dpc embryos after 
c-Kit (CD117) enrichment using magnetic-activated 
cell-sorting columns (Miltenyi Biotec). 10,000 LSK cells 
were simultaneously transduced with mouse stem cell virus 
(MSCV)–Meis1a-puro and MSCV–Hoxa9-neo retroviruses 
and subsequently subjected to three rounds of CFC assays in 
MethoCult (M3231) supplemented with 20 ng/ml stem cell 
factor, 10 ng/ml IL-3, 10 ng/ml IL-6, and 10 ng/ml granu-
locyte/macrophage stem cell factor. Colonies were counted 
6–7 d after plating, and 2,500 cells were replated. Similarly, 
200,000 FL c-Kit+ cells were transduced with MSCV–
AML1-ETO9a-neo, MSCV–MLL-AF9-neo, or MSCV–
MLL-ENL-neo and subsequently plated into methylcellulose.
transplantation assays
Lethal irradiation of CD45.1+/CD45.2+ recipient mice was 
achieved using a split dose of 11 Gy (two doses of 5.5 Gy 
administered at least 4 h apart) at a mean rate of 0.58 Gy/min 
using a Cesium 137 irradiator (GammaCell 40; Best Ther-
atronics). For sublethal irradiation, the recipient mice received 
a split dose of 7 Gy (two doses of 3.5 Gy at least 4 h apart).
For primary transplantations, 100 HSCs (LSK 
CD48−CD150+CD45.2+) sorted from FLs of 14.5-dpc em-
bryos or 200,000 unfractionated FL cells were mixed with 
200,000 support CD45.1+ BM cells and injected into le-
thally irradiated (11 Gy delivered in a split dose) CD45.1+/
CD45.2+ recipient mice. For secondary transplantations, 
2,000 CD45.2+ LSK cells sorted from BM of primary recip-
ients were mixed with 200,000 support CD45.1+ wild-type 
BM cells and retransplanted. For adult BM transplantations, 
500,000 CD45.2+ BM cells were mixed with 500,000 sup-
port CD45.1+ wild-type BM cells and injected into le-
thally irradiated CD45.1+/CD45.2+ recipient mice. All 
recipient mice were analyzed 18–20 wk after transplantation, 
unless otherwise stated.
For leukemia induction, 100,000 Meis-1/Hoxa9-trans-
duced c-Kit+ cells were transplanted into CD45.1+/CD45.2+ 
sublethally irradiated (7 Gy delivered in a split dose) recipi-
ent mice. The mice were monitored for AML development. 
For secondary transplantation, 10,000 LICs (CD45.2+c-Kit+ 
cells) were sorted from BM of primary recipients and trans-
planted into secondary CD45.1+/CD45.2+ sublethally ir-
radiated recipient mice.
Inducible Mx1-cre–mediated gene deletion
Mice were injected intraperitoneally six to eight times every 
alternate day with 300 µg pIpC (GE Healthcare) as previously 
described (Kranc et al., 2009; Guitart et al., 2013).
Administration of nAc
Pregnant females received 30 mg/ml of NAC (Sigma- 
Aldrich) in drinking water (pH was adjusted to 7.2–7.4 with 
NaOH). For transplantation experiments, CD45.1+/CD45.2+ 
recipient mice were treated with 30 mg/ml NAC in drinking 
water 7 d before irradiation and remained under NAC treat-
ment for the duration of the experiment. The water bottle 
containing NAC was changed twice per week.
oxygen consumption assays
OCR measurements were made using a Seahorse XF-24 an-
alyzer (Seahorse Bioscience) and the XF Cell Mito Stress Test 
kit as previously described (Wang et al., 2014). In brief, c-Kit+ 
cells from FLs of 14.5-dpc embryos were plated in XF-24 
microplates precoated with cell-tak (BD) at 250,000 cells per 
well in XF Base medium supplemented with 2 mM pyruvate 
and 10 mM glucose, pH 7.4. OCR was measured three times 
every 6 min for basal value and after each sequential addition 
of oligomycin (1 µM), FCCP (1 µM), and finally concomi-
tant rotenone and antimycin A (1 µM). Oxygen consumption 
measurements were normalized to cell counts performed be-
fore and after each assay.
Metabolite detection by liquid chromatography–
mass spectrometry (lc-MS)
Metabolites from c-Kit+ cells from FLs of 14.5-dpc embryos 
were extracted into 50% methanol/30% acetonitrile and 
measured as previously described (Adam et al., 2013).
Western blotting
Protein extracted from FL c-Kit+ cells of 14.5-dpc embryos 
was subjected to a 10% SDS–PAGE and then transferred onto 
a polyvinylidene fluoride membrane and immunoblotted with 
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anti-Fh1, anti–2-SC, and anti–Hif-1α as previously described 
(Adam et al., 2011; Bardella et al., 2012). Anti-H3K4me3 (07-
473; EMD Millipore), anti-H3K9me3 (ab8898; Abcam), an-
ti-H3K27me3 (07-449; EMD Millipore), and anti-H3K36me3 
(ab9050; Abcam) were used to determine levels of trimeth-
ylated H3. Anti-actin (A5316; Sigma-Aldrich), anti-tubulin 
(2146S; Cell Signaling Technology), and anti-H3 (ab1791; 
Abcam) immunoblots were used as loading controls.
rt–quantitative Pcr
Gene expression analyses were performed as described pre-
viously (Kranc et al., 2009; Mortensen et al., 2011; Guitart et 
al., 2013). Differences in input cDNA were normalized with 
Actb (β-actin) expression.
AtP production
10,000 c-Kit+ cells from FLs of 14.5-dpc embryos were cul-
tured in DMEM supplemented with either 25 mM glucose 
or 25 mM galactose. At 0 and 24 h after incubation, the cells 
were lysed, and ATP content was measured by luminescence 
using CellTiterGlo Assay (Promega).
Measurement of mitochondrial membrane potential
50,000 FL c-Kit+ cells from 14.5-dpc embryos were incu-
bated for 15 min at 37°C in 25 nM tetramethylrhodamine 
methyl ester (T-668; Thermo Fisher Scientific) and analyzed 
using the LSRFortessa flow cytometer.
Gene expression profiling and bioinformatics analyses
RNA from sorted FL Lin−c-Kit+ cells was isolated by stan-
dard phenol/chloroform extraction. cDNA was synthesized 
from 50 ng of total RNA using the Ambion WT Expression 
kit (Thermo Fisher Scientific). Labeled, fragmented cDNA 
(GeneChip WT Terminal Labeling and Controls kit; Affyme-
trix) was hybridized to Mouse Gene 2.0 arrays for 16 h at 
45°C and 60 rpm (GeneChip Hybridization, Wash, and Stain 
kit; Affymetrix). Arrays were washed and stained using the 
Fluidics Station 450 (Affymetrix) and scanned using a Gene-
Array Scanner (3000 7G; Hewlett-Packard). The microarray 
gene expression data have been deposited in the ArrayExpress 
database under accession no. E-MTAB-5425.
For bioinformatics analyses, a total of seven arrays (n = 
3 Fh1fl/fl; n = 4 Fh1fl/fl;Vav-iCre) were quality control an-
alyzed using the arrayQualityMetrics package in Biocon-
ductor. Normalization of the 29,638 features across all arrays 
was achieved using the robust multiarray average expression 
measure. Pairwise group comparisons were undertaken using 
linear modeling (LIM MA package in Bioconductor). Sub-
sequently, empirical Bayesian analysis was applied, including 
vertical (within a given comparison) p-value adjustment for 
multiple testing, which controls for false discovery rate.
Gene set enrichment analysis (GSeA)
Gene expression differences were ranked by difference of 
log expression values, and this ranking was used to perform 
GSEA (Subramanian et al., 2005) on gene lists in the Molecu-
lar Signatures Database (MSigDB; version 5.2). The following 
datasets were used for analyses presented in Fig. 4: (a) hall-
mark, unfolded protein response; (b) gene ontology, intrinsic 
apoptotic signaling pathway in response to endoplasmic re-
ticulum stress; (c) reactome, translation; and (d) NFE2L2.V2.
shrnA-mediated FH knockdown
THP-1 cells were transduced with lentiviruses expressing 
shRNAs (shRNA1, 5′-TAA TCC TGG TTT ACT TCA GCG-
3′ [TRCN0000052463]; shRNA2, 5′-AAG GTA TCA TAT 
TCT ATC CGG-3′ [TRCN0000052464]; shRNA3, 5′-TTT 
ATT AAC ATG ATC GTT GGG-3′ [TRCN0000052465]; 
and shRNA Scr, 5′-TTC TCC GAA CGT GTC ACG TT-3′; 
RNAi Consortium; GE Healthcare). Transduced THP-1 cells 
were grown in the presence of 5 µg/ml puromycin.
roS analysis
c-Kit+ cells were stained with 2.5 nM CellROX (C10491; 
Thermo Fisher Scientific) based on the manufacturer’s proto-
col and analyzed by FACS.
Statistical analyses
Statistical analyses were performed using Prism 6 (Graph-
Pad Software). P-values were calculated using a two-tailed 
Mann-Whitney U test unless stated otherwise. Kaplan-Meier 
survival curve statistics were determined using the 
log-rank (Mantel-Cox) test.
online supplemental material
Table S1 shows neutropenia in patients with recessive FH 
mutations. Table S2 shows hematopoiesis-specific Fh1 dele-
tion results in embryonic lethality. Table S3 shows FHCyt res-
cues embryonic lethality in Fh1fl/fl;Vav-iCre mice.
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